Recently, emerging evidence has suggested that RGS proteins play a fundamental role not only in embryonic development but also in various diseases, including gestational disorders as well as gynecological diseases including gynecology malignancies [11–13], such as ovarian carcinoma and hysteromyoma (Fig. 2). Here, PITX2 is linked to ovarian carcinoma.